在神经元内,Apolipoprotein E 与粉样β相交
Sabine C Konings1,2, Emma Nyberg1, Isak Martinsson1
1Experimental Dementia Research Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden.
Life science alliance
|June 8, 2023
概括
脂蛋白E4 (ApoE4) 是阿尔茨海默病 (AD) 的一个主要风险因素. 这项研究表明,内部化的ApoE与神经元内的粉样蛋白前体蛋白/Aβ相互作用,为AD病变发生提供了新的见解.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 细胞生物学 细胞生物学
背景情况:
- 阿波利波蛋白E4 (ApoE4) 是阿尔茨海默病 (AD) 的主要遗传风险因素.
- 早期的AD病理包括神经元内体扩大,特别是在ApoE4载体中.
- 粉样蛋白前体蛋白 (APP) 和它的片段β-粉样蛋白 (Aβ) 在AD早期在神经元内体中积聚.
研究的目的:
- 为了研究神经元细胞内的阿波利波蛋白E (ApoE) 和β-粉样蛋白 (Aβ) 的细胞内交叉.
- 为了确定神经元和星球细胞中内化ApoE的差异细胞局部.
- 在阿尔茨海默氏病模型中阐明ApoE4在Aβ积累和细胞内相互作用中的作用.
主要方法:
- 使用神经母细胞瘤细胞,初级星体细胞和神经元进行细胞局部化研究.
- 在健康和AD转基因神经元模型中对内部化星细胞ApoE的分析.
- 在不同ApoE条件下,对神经元内源性和内化Aβ42水平的量化.
主要成果:
- 内部化天体细胞 ApoE 显示了差异化的局部化:在天体细胞/神经母细胞细胞中的 lysosomes,在神经元神经元细胞中的 endosomes-autophagosomes.
- 发现来自天体细胞的ApoE与AD转基因模型的神经元中的粉样蛋白前体蛋白/Aβ细胞内交叉.
- ApoE4显著增加了神经元内的内源性和内化Aβ42的水平.
结论:
- 内化ApoE在不同细胞类型中表现出不同的亚细胞局部化模式,在神经元内体-自体中优先积累.
- 在神经元中,ApoE与APP/Aβ的细胞内交叉代表了一项新发现,对AD病变发生有潜在影响.
- ApoE4加剧神经元中的Aβ42积累,突出其在AD进展中的关键作用,并建议治疗点.
相关概念视频
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Alzheimer's Disease: Overview
536
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
536


